Bio Protocol vs Casper — how do they compare? Bio Protocol trades at Rp518.5 (market cap Rp1,17T, Rp248,44M 24h volume), while Casper trades at Rp31.99 (market cap Rp534,42M, Rp36,72M 24h volume). The key difference: Bio Protocol is far larger — about 2189.3× Casper's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Casper's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Casper for 13 Days on average.
| BIO | CSPR | |
|---|---|---|
Market Cap | Rp1,17T | Rp534,42M |
Volume (24h) | Rp248,44M | Rp36,72M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 16,6B CSPR |
Typical Hold Time | 16 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp521.46 with a market cap of Rp1.16T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token's circulating supply of 2.2M out of 3.3M max supply (68% circulation) suggests controlled token distribution. Current price sits near the pivot point of Rp521 with immediate support at Rp508 and resistance at Rp530. Recent market activity shows average hold time of 16 days, indicating relatively short-term trading patterns in the current bearish environment.
Overall outlook remains cautious with technical indicators favoring sellers, though oversold RSI conditions may present short-term bounce opportunities. Key risks include continued bearish momentum and low trading volumes, while potential upside could come from any positive ecosystem developments or market-wide crypto recovery. Investors should monitor support levels closely for entry points.
Casper (CSPR) is currently trading at Rp33,699 with a market cap of Rp534.42 million, showing bearish technical signals overall. The asset is trading below the pivot point of Rp34, with immediate support at Rp32 and resistance at Rp36. While moving averages indicate strong bearish momentum, oscillators remain neutral with mixed signals from RSI and ADX indicators. No major protocol updates or ecosystem developments have been reported recently.
The overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential rebounds from oversold conditions near support levels, while major risks involve continued downward pressure and limited liquidity. Investors should monitor network activity and exchange volume trends for signs of renewed interest in the token.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Casper is a Proof-of-Stake Layer-1 blockchain aimed at bringing real-world assets on-chain. Launched on the mainnet in March 2021, Casper provides infrastructure for tokenized assets, featuring upgradable smart contracts, protocol-level access control, and native support for multiple virtual machines (VMs).
Read more on CSPR →